WHO publishes updated living guideline on therapeutics and Covid-19, WHO

Based on the results of a systematic review and meta-analysis, the guideline panel makes new strong recommendations against the use of hydroxychloroquine and lopinavir/ritonavir in patients with Covid-19, regardless of disease severity.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news